Abbvie Contract MFG

  Challenges Manufacturers Encounter During Aseptic Fill Finishing Aseptic fill finishing can be quite challenging, as asepsis techniques involve procedures that eliminate harmful spores, pathogens, parasites, viruses, and fungi. These procedures require careful planning from thoroughly trained personnel. The facilities and equipment used for this procedure are specialized and require expert care and handling. Any errors encountered during any of the drug development processes, storage, and transportation can affect how safe and efficacious the drugs are. Here are four of the most common challenges manufacturers face during fill finishing manufacturing . Four Challenges Encountered 1.Protein Structure and Stability When it comes to the manufacturing of protein-based drugs for large scale commercialization, many factors need to be considered. Different process parameters come into play when dealing with the production of drugs, from processing to storage and transportation. Each of ...

  Three Things Every Drug Manufacturer Should Have in Place Before Personally Handling their Fill Finish Fill finish is the last and arguably the most important stage in drug manufacturing. In layman's terms, fill finish refers to transferring a sterile drug from a sterile needle to a sterile container. This is a crucial part of the entire biopharmaceutical manufacturing process.  Fill finish is a common bottleneck in the manufacturing process; that's why manufacturers look to partner with a reliable third-party provider. However, the challenge is in choosing the right partner; we're here to make that decision a lot easier to make. Three Criteria That Should be in Place Before Any Fill Finish Process is Initiated Industry Standard Procedures In the pharmaceutical space, tried and true industry practices should always be the topmost priority; this should be your core message. Whether you’re choosing a third-party provider to contract your fill finish manufacturing or you ho...

  Fill and Finish Cell Therapy Abbvie Contract Manufacturing has the leading experts and a global network to scale-up and scale-out drug fill-finish , allogeneic and autologous therapies. Our cGMP manufacturing services deliver excellent operations, customer satisfaction, and future vision for your therapeutic product. Our state-of-the-art CGMP facilities are both FDA and EMA compliant, offering flexibility and confidence in manufacturing at a worldwide scale. Our expert development and manufacturing teams are sophisticated, and we partner with our gene therapy teams for viral vector production. This brings your cell therapy product from development to industrialization in a seamless process. Each facility has commercial manufacturing, clinical, and development operations offering full-service capabilities for our client needs. At Abbvie Contract Manufacturing, we excel in various projects, including suspension and adherent cells.  We have completed several projects as a strat...

  Abbvie Biologics' Drug Product Development Abbvie Biologics' drug development and manufacturing services leverage its proven expertise to provide biologics, biosimilars, and vaccines. Abbvie has extensive experience with drug fill finish process development for all its phases. Our scientists have experience in different sort of formulations and merchandise presentations for your drug product formulation. Whether your molecule needs vials (liquid or lyophilized) or syringes, Abbvie's high-speed filling lines offer the absolute best degree of aseptic processing. They are integrated with secondary packaging to supply your clinical or commercial product to patients reliably. Process Development From cell culture through recovery and purification, our scientists develop processes that ensure consistent CGMP manufacturing performance and a reliable product supply. The use of identical bioreactors helps a smooth transition from non-GMP to GMP manufacturing. Comprehensive, integ...

  Why Aseptic Fill Finish is Essential to the Pharmaceutical Industry An aseptic fill finish , also known as sterile filling of drugs, is the last and one of the most challenging stages in the drug creation processes. This process is so complex because it requires careful planning, thoroughly trained workers, and specialized facilities/ equipment to pull it off. It also requires close coordination and complex interactions between the persons operating the systems, sterilized products, clean room, and sterilized filling equipment. This process of fill finish manufacturing is a process that relies significantly on a perfect technique, and slight errors can have a significant impact on the end-users. Considering that these sterile drugs are to be used on already compromised patients, it is important that they relieve and not further complicate the situation. Many complex biochemical, pharmaceutical, and biotechnology drugs products wouldn't be able to undergo terminal sterilization ri...

  An Overview of Aseptic FillFinish Aseptic fillfinish first hit the market in the 1920s. For a drug, this can be considered relatively recent, and it was created out of the need to meet the needs of injectables and large scale manufacturing of blood and plasma during WWII.  The world needed certain drugs that couldn't undergo the rigors of the previously used filtration processes. Plasma, for example, did and still has significant use in the hospital, and previously had to undergo a post-fill filtration of low heat treatment.  This pasteurization process wasn’t effective as it didn’t sterilize the plasma but only reduced the chances of getting contaminated by fungi. Back then, anti-fungal reagents may also have been added to parental drugs to reduces their chances of contamination.  The world saw her first glimpse of what we now called aseptic fill-finish in 1981. That was when the Parental Drug Association published its Aseptic Validation Technical to improve the ...

The Demand for Medicine Fill Finish Operations Error-free fill-finish operations in pharmaceutical and biopharmaceutical manufacturing are crucial to making sure of patient safety. The growing diversity of biologic drugs also has a part in products targeted for parenteral delivery in the demand for aseptic fill-finish operations. However, to effectively meet this growing demand for fill-finish services requires specialized expertise. This includes appropriate equipment and innovations in both emerging technology and business models. Fill-Finish Manufacturing In pharmaceutical manufacturing, fill-finish operations are critical. They are the last step before a product is packaged and delivered to the patient. A drug product is highly valuable at this step. It has been through labor- and cost-intensive production stages. Stages like upstream processing, cell culture or fermentation, and downstream purification. Failures within the integrity of the fill-finish stage can introduc...